Skip to main content
Loading

Opening Address & Keynote Presentation: Casting a wide net – covering the breadth of CNS diseases as a CRO

10 Sept 2026
Target Discovery Biomarkers Blood Brain Barrier Preclinical Models Clinical Development

There are over 600 CNS diseases, covering neurology, neurodegeneration, psychiatry, and neurodevelopmental. Is it possible to establish a neuroscience platform that can cast a wide enough net to address this number and diversity of CNS diseases? Building a platform that focusses on disease agnostic mechanisms, pathways, and symptoms that are common across CNS diseases allows one to understand underlying biology. Interrogating these mechanisms and pathways with drugs provides optionality for drug discovery programs.    

Industry Expert
Max Mirza, Vice President - Neuroscience Drug Discovery - Sygnature Discovery